Compliance

Article | January 25, 2022

Wishful Thinking by FDA that COVID-19 May Be Coming to an End?

Article | December 13, 2021

9 Months After Mallory: Keeping Independent Contractors Independent

Article | December 01, 2021

Are drug and device makers with weak cybersecurity violating the False Claims Act?

Article | October 27, 2021

“The Long and Winding Road that Leads”… Back to Where We Started? FDA Amends its Intended Use Regulations

Article | June 07, 2021

Sunny Skies Turn Dark as Sunshine Act Enforcement Ramps

Article | May 05, 2021

In the Wake of the Safe Harbor Updates - Key Takeaways

Article | April 13, 2021

Privacy Update for Drug & Device Makers

Article | December 03, 2020

2020 Regulatory Update from Both Sides of the Pond

Article | November 23, 2020

OIG issues Special Fraud Alert on Speaker Programs

Article | August 25, 2020

GDPR update: Why did a European court recently invalidate the EU-US Privacy Shield?

Article | July 30, 2020

Are you promoting products virtually in the COVID era?

Article | November 18, 2019

Regulatory update from both sides of the pond

Article | October 15, 2019

How to avoid "going viral" with the FDA

Article | September 08, 2019

Have you completed your 2019 Audit?

Article | July 01, 2019

Are you meeting the new transparency requirements?

Article | June 22, 2019

Does your compliance program meet the revised AdvaMed Code?

« 1 2